Discordance between aPTT and anti‐Xa in monitoring heparin anticoagulation in mechanical circulatory support

Authors: Song Li, Ang Li, Jennifer A. Beckman, Christopher Kim, Marian A. Granich, John Mondin, Daniel E. Sabath, David A. Garcia, Claudius Mahr

Source: ESC Heart Failure, Vol 11, Iss 5, Pp 2742-2748 (2024)

Subject Terms: Anti‐factor Xa, Drug monitoring, Heparin anticoagulation, Partial thromboplastin time, Ventricular assist device, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/2055-5822

Access URL: https://doaj.org/article/af43917cba584ceab8863df952330cb1

Distribution of anti‐factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban

Authors: Shotaro Hiramatsu, Hiroyuki Osanai, Yuichiro Sakai, Yoshiki Sogo, Yuki Tanaka, Hikari Matsumoto, Shun Miyamoto, Kensuke Tagahara, Kenji Arai, Takashi Watanabe, Yusuke Sakamoto, Teruhiro Sakaguchi, Shioh Oguchi, Takahiro Kanbara, Yoshihito Nakashima, Hiroshi Asano, Masayoshi Ajioka

Source: Journal of Arrhythmia, Vol 40, Iss 5, Pp 1126-1130 (2024)

Subject Terms: anticoagulant, anti‐factor Xa, atrial fibrillation, edoxaban, stroke, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/1880-4276; https://doaj.org/toc/1883-2148

Access URL: https://doaj.org/article/135492f6dc2b4386ad9fdafe4fe9c0d5

Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: A comparison between aPTT and anti-factor Xa activity level monitoring

Authors: Reuland, Merijn C. ^{a, ⁎}, van Haaps, Thijs F. ^{b, 1}, Broeren, Pieter O.L.P. ^a, van Es, Nick ^b, Dijkslag-van der Laan, Claire E. ^b, Vlaar, Alexander P.J. ^a, Coppens, Michiel ^b, Müller, Marcella C.A. ^a

Source: In Thrombosis Update June 2025 19

Pregnant Woman in Outcomes with Prosthetic Heart Valves

Authors: Giunai Sefiyeva, Ulyana Shadrina, Tatiana Vavilova, Olga Sirotkina, Andrey Bautin, Aigul Chynybekova, Anna Pozhidaeva, Ekaterina Stepanovykh, Anna Starshinova, Dmitry Kudlay, Olga Irtyuga

Source: Journal of Cardiovascular Development and Disease, Vol 11, Iss 11, p 353 (2024)

Subject Terms: pregnant woman, prosthetic heart valves, mechanical valve prostheses, biological valve prosthesis, anti-factor Xa, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.mdpi.com/2308-3425/11/11/353; https://doaj.org/toc/2308-3425

Access URL: https://doaj.org/article/fc16a64ba80a4203b7c5bb9614587a26

Pilot study examining anti-factor Xa levels for heparin monitoring and outcomes in patients with cerebral venous thrombosis

Authors: Yasaman Pirahanchi, Kristin Salottolo, Christian Burrell, Xu Tang, David Bar-Or, Russell Bartt

Source: Frontiers in Medicine, Vol 11 (2024)

Subject Terms: cerebral venous thrombosis, unfractionated heparin, anti-factor-Xa, monitoring, outcomes, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2024.1317246/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/1d9a1a7da6664bfe8361c941464c0dfc

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most

Authors: Mauricio Concha, Lizhen Xu, MacKenzie Horn, Tomoyuki Ohara, Juliet Nakamya, Jan Beyer‐Westendorf, Ashkan Shoamanesh, Alexander Cohen, Per Ladenvall, Stuart J. Connolly, Andrew M. Demchuk

Source: Stroke: Vascular and Interventional Neurology, Vol 4, Iss 1 (2024)

Subject Terms: andexanet alfa, anti‐factor Xa activity, direct factor Xa inhibitor reversal, hematoma expansion, intracranial hemorrhage, Neurology. Diseases of the nervous system, RC346-429, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/2694-5746

Access URL: https://doaj.org/article/9afe5c2bf3dd4bf3923c253ead8387eb

Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay

Authors: Renata Jurema Medeiros, Nathália Pessoa Gonçalves, Magno Maciel Magalhães, João Ferreira Martins, Tiago Savignon Cardoso Machado

Source: Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, Vol 11 (2023)

Subject Terms: Heparin, Anti-factor Xa Assay, Anti-factor IIa Assay, Quality Control, Human Health, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1923; https://doaj.org/toc/2317-269X

Access URL: https://doaj.org/article/53ba1a25eff74db089bc9fe41a155c13

Use of Biomarkers in Pharmacokinetics Studies of Medicinal Products of Natural Origin

Authors: V. M. Kosman, N. M. Faustova, M. V. Karlina, V. G. Makarov, M. N. Makarova

Source: Регуляторные исследования и экспертиза лекарственных средств, Vol 11, Iss 1, Pp 24-35 (2021)

Subject Terms: pharmacokinetics, medicinal products of natural origin, biological activity, biomarkers, anti-factor xa, dipeptidyl peptidase 4, lactate dehydrogenase, enzymatic assay, kinetic methods, fucoidan, fucus vesiculosus, biologically active compounds, glycosylated polypeptide, strongylocentrotus droebachiensis, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.vedomostincesmp.ru/jour/article/view/349; https://doaj.org/toc/3034-3062; https://doaj.org/toc/3034-3453

Access URL: https://doaj.org/article/58dcd174adc948b0a1a8060784d9ee58

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study

Authors: Christoph Dibiasi, Johannes Gratz, Marion Wiegele, Andreas Baierl, Eva Schaden

Source: Frontiers in Medicine, Vol 9 (2022)

Subject Terms: anti-factor Xa activity, low molecular weight heparin, thromboprophylaxis, venous thromboembolism, critical illness, anticoagulation, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2022.888451/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/4b134a693d6f487c80049556fc6fc570

In vivo real-time monitoring of anti-factor Xa level using a microdialysis-coupled microfluidic device

Authors: Xingbei Zhou, Tao Ding, Shushui Wang, Longping Wen

Source: Talanta Open, Vol 4, Iss , Pp 100059- (2021)

Subject Terms: Anti-factor Xa, Microdialysis, Microfluidic, Real-time monitoring, Therapeutic drug monitoring, Analytical chemistry, QD71-142

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666831921000291; https://doaj.org/toc/2666-8319

Access URL: https://doaj.org/article/662bfa737457418d86271655d4c153d3

Assessing Anticoagulation in Neonates With Congenital Diaphragmatic Hernia During Extracorporeal Membrane Oxygenation: Does Anti-Factor Xa or Thromboelastometry Provide Additional Benefit?

Authors: Alba Perez Ortiz, Carl E. Dempfle, Toni Jung, Thalia Doniga, Christel Weiß, Svetlana Hetjens, Thomas Schaible, Neysan Rafat

Source: Frontiers in Pediatrics, Vol 9 (2021)

Subject Terms: extracorporeal membrane oxygenation, congenital diaphragmatic hernia, thromboelastometry, anti-factor Xa, heparin, Pediatrics, RJ1-570

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fped.2021.685906/full; https://doaj.org/toc/2296-2360

Access URL: https://doaj.org/article/4b480256ab2d49bfb732f00ee73c09ef

Anti–factor Xa activity assays of direct‐acting oral anticoagulants during clinical care: An observational study

Authors: Smrithi Sukumar, Melissa Cabero, Sharon Tiu, Margaret C. Fang, Scott C. Kogan, Janice B. Schwartz

Source: Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 4, Pp n/a-n/a (2021)

Subject Terms: anti–factor Xa activity assay, apixaban, direct oral anticoagulant, retrospective electronic medical record, rivaroxaban, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2475-0379

Access URL: https://doaj.org/article/0a302612103c446db244cd46a0ba11a0

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

Authors: Tahaineh L, Edaily SM, Gharaibeh SF

Source: Clinical Pharmacology: Advances and Applications, Vol Volume 10, Pp 63-70 (2018)

Subject Terms: Anti-factor Xa, anticoagulation, enoxaparin, obesity, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.dovepress.com/anti-factor-xa-levels-in-obese-patients-receiving-enoxaparin-for-treat-peer-reviewed-article-CPAA; https://doaj.org/toc/1179-1438

Access URL: https://doaj.org/article/df87d9ab82574242b6cbd410b1584d3a

Heparins: A Shift of Paradigm

Authors: H. Coenraad Hemker, Raed Al Dieri, Suzette Béguin

Source: Frontiers in Medicine, Vol 6 (2019)

Subject Terms: heparin, low molecular weight heparin (LMWH), thrombin generation, endogenous thrombin potential (ETP), anti-thrombin activity, anti-factor Xa activity, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fmed.2019.00254/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/5790160a584149a9b945ee95128a3e6f

Prophylactic anti-coagulation after severe burn injury in critical care settings

Authors: Megan Blake, Ruth Roadley-Battin, Tomasz Torlinski

Source: Acta Medica Lituanica, Vol 26, Iss 1 (2019)

Subject Terms: anticoagulation, thromboprophylaxis, burns, intensive care, heparin, Anti-Factor Xa, Medicine

File Description: electronic resource

Relation: https://www.journals.vu.lt/AML/article/view/21273; https://doaj.org/toc/1392-0138; https://doaj.org/toc/2029-4174

Access URL: https://doaj.org/article/a115c661810a49289aa6c0a5cb0d090b

Clinical implication of monitoring rivaroxaban and apixaban by using anti-factor Xa assay in patients with non-valvular atrial fibrillation

Authors: Kozue Ikeda, MD, Hideaki Tachibana, MD

Source: Journal of Arrhythmia, Vol 32, Iss 1, Pp 42-50 (2016)

Subject Terms: Atrial fibrillation, Direct factor Xa inhibitor, Anti-factor Xa activity, Chromogenic assay, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1880427615001064; https://doaj.org/toc/1880-4276

Access URL: https://doaj.org/article/2165f69d2a494c0f9623b442d29bc025

Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin

Authors: Satheesh Jogala, Shyam Sunder Rachamalla, Jithan Aukunuru

Source: Journal of Advanced Pharmaceutical Technology & Research, Vol 6, Iss 2, Pp 58-64 (2015)

Subject Terms: Anti-factor Xa activity, low molecular weight heparin, nanoparticles, polylactide co-glycolide, subcutaneous, sustained release, Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: http://www.japtr.org/article.asp?issn=2231-4040;year=2015;volume=6;issue=2;spage=58;epage=64;aulast=Jogala; https://doaj.org/toc/2231-4040; https://doaj.org/toc/0976-2094

Access URL: https://doaj.org/article/e0e572c6df98402292b2800f4a138a55

Biological potency evaluation and physicochemical characterization of unfractionated heparins

Authors: Dalmora, Sérgio L., Souto, Ricardo B., Silva, Lucélia M., Lana, Aline D., Schutkoski, Renato, Vaccari, Silvana F.

Source: Revista Brasileira de Hematologia e Hemoterapia. January 2009 31(5)

Subject Terms: Unfractionated heparins, anti-factor Xa, activated partial thromboplastin time, anti-factor IIa, protamine, capillary electrophoresis

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000500009

Biological potency evaluation and physicochemical characterization of unfractionated heparins Avaliação biológica de potência e caracterização físico-química de heparinas não fracionadas

Authors: Sérgio L. Dalmora, Ricardo B. Souto, Lucélia M. Silva, Aline D. Lana, Renato Schutkoski, Silvana F. Vaccari

Source: Revista Brasileira de Hematologia e Hemoterapia, Vol 31, Iss 5, Pp 326-332 (2009)

Subject Terms: Heparinas não fracionadas, anti-fator Xa, tempo de tromboplastina parcial ativada, anti-fator IIa, protamina, eletroforese capilar, Unfractionated heparins, anti-factor Xa, activated partial thromboplastin time, anti-factor IIa, protamine, capillary electrophoresis, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000500009; https://doaj.org/toc/1516-8484; https://doaj.org/toc/1806-0870

Access URL: https://doaj.org/article/7856e61ba94647f18c345253f91a2e88

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Authors: Mario A. Inchiosa, Jr, author^{1, 2}, Suryanarayana Pothula, author², Keshar Kubal, author^{1, 2}, Vajubhai T. Sanchala, author², Iris Navarro, author²

Source: Journal of Visualized Experiments. (68)

Availability: http://www.jove.com/video/3852